BCTX
Briacell Therapeutics
BCTX
BCTX
13 hedge funds and large institutions have $94.1K invested in Briacell Therapeutics in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
13
Holders Change
-12
Holders Change %
-48%
% of All Funds
0.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
6
Reduced
1
Closed
14
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
-$86K
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
+$60K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$4K |
| 3 |
Morgan Stanley
New York
|
+$1.76K |
| 4 |
National Bank of Canada
Montreal,
Quebec, Canada
|
+$1.31K |
| 5 |
SS
SBI Securities
Tokyo,
Japan
|
+$986 |
Top Sellers
| 1 |
Vontobel Holding
Zurich,
Switzerland
|
-$62.2K |
| 2 |
CF
Cantor Fitzgerald
New York
|
-$31.6K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$28.6K |
| 4 |
OBWG
Onyx Bridge Wealth Group
Tarrytown,
New York
|
-$28.3K |
| 5 |
VF
Virtu Financial
New York
|
-$27K |
